Clinical Trials Logo

Clinical Trial Summary

Retrospectively review the clinical characteristics of patients with multiple endocrine neoplasia type I in National Taiwan University Hospital.


Clinical Trial Description

The investigators will retrospectively review the clinical characteristics of patients with multiple endocrine neoplasia type I in National Taiwan University Hospital. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05812573
Study type Observational
Source National Taiwan University Hospital
Contact Shyang-Rong Shih, MD, PhD
Phone +886-972653337
Email srshih@ntu.edu.tw
Status Recruiting
Phase
Start date March 14, 2023
Completion date February 14, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03053999 - Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)
Recruiting NCT03048266 - Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients
Recruiting NCT04028479 - The Registry of Oncology Outcomes Associated With Testing and Treatment
Completed NCT00501449 - Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes
Terminated NCT00947167 - A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors Phase 2
Completed NCT00204373 - Treatment of Zollinger-Ellison Syndrome With Prevacid Phase 4
Recruiting NCT03348501 - Study and Follow-up of Multiple Endocrine Neoplasia Type 1 N/A
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed NCT00990535 - High Dose Somatostatin Analogues in Neuroendocrine Tumors Phase 2
Completed NCT00001277 - Studies of Elevated Parathyroid Activity Phase 2
Completed NCT00001345 - Studies of Inherited Diseases of Metabolism